Syneos Health, Inc.
DelistedCIK 1610950fmd_1F6HX7E30DQY4N6DD59Q9J4PFSServices · Services-Commercial Physical & Biological ResearchTemplate: Standard
Coverage: Jan 01, 2012 to Jun 30, 2023, 43 periods
| Line item | FY2013 | FY2014 | FY2015 | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenues | 995 | 1,179 | 1,399 | 1,611 | 2,672 | 4,390 | 4,676 | 4,416 | 5,213 | 5,393 |
| Cost of revenue | 775 | 884 | 1,027 | 1,207 | 1,232 | 3,434 | 3,646 | 3,398 | 3,994 | 4,139 |
| Gross profit | 220 | 295 | 372 | 404 | 1,440 | 956 | 1,030 | 1,018 | 1,218 | 1,254 |
| Selling, general and administrative | 118 | 145 | 157 | 172 | 283 | 406 | 508 | 473 | 571 | 547 |
| Operating income | 31 | 64 | 152 | 155 | (29) | 160 | 238 | 293 | 389 | 403 |
| Interest expense | 61 | 53 | 16 | 12 | 64 | 131 | 130 | 91 | 79 | 82 |
| Interest and investment income | 0 | 0 | 0 | 0 | 1 | 4 | 8 | 0 | 0 | 2 |
| Other non-operating income (expense) | (62) | (92) | (21) | (21) | (83) | (103) | (136) | (89) | (74) | (89) |
| Income before taxes | (31) | (28) | 131 | 134 | (112) | 57 | 102 | 204 | 315 | 315 |
| Income tax expense | 11 | (5) | 14 | 21 | 27 | 33 | (30) | 11 | 80 | 48 |
| Net income from continuing operations | (42) | (23) | 117 | 113 | (138) | 24 | 131 | 193 | 235 | 266 |
| Net income | (42) | (23) | 117 | 113 | (138) | 24 | 131 | 193 | 235 | 266 |
| Net income to common shareholders | (42) | (27) | 117 | 113 | (138) | 24 | – | – | – | – |